373 related articles for article (PubMed ID: 19059053)
1. The role of iron in patients after bone marrow transplantation.
de Witte T
Blood Rev; 2008 Dec; 22 Suppl 2():S22-8. PubMed ID: 19059053
[TBL] [Abstract][Full Text] [Related]
2. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
3. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
[TBL] [Abstract][Full Text] [Related]
4. Iron overload in hematopoietic cell transplantation.
Majhail NS; Lazarus HM; Burns LJ
Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
6. Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation.
Brissot E; Savani BN; Mohty M
Semin Hematol; 2012 Jan; 49(1):35-42. PubMed ID: 22221783
[TBL] [Abstract][Full Text] [Related]
7. The deleterious effects of iron overload in patients with myelodysplastic syndromes.
Dreyfus F
Blood Rev; 2008 Dec; 22 Suppl 2():S29-34. PubMed ID: 19059054
[TBL] [Abstract][Full Text] [Related]
8. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
Inati A; Kahale M; Sbeiti N; Cappellini MD; Taher AT; Koussa S; Nasr TA; Musallam KM; Abbas HA; Porter JB
Pediatr Blood Cancer; 2017 Jan; 64(1):188-196. PubMed ID: 27576370
[TBL] [Abstract][Full Text] [Related]
9. Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress.
Evens AM; Mehta J; Gordon LI
Bone Marrow Transplant; 2004 Oct; 34(7):561-71. PubMed ID: 15286699
[TBL] [Abstract][Full Text] [Related]
10. Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.
Atilla E; Toprak SK; Demirer T
Turk J Haematol; 2017 Mar; 34(1):1-9. PubMed ID: 27956374
[TBL] [Abstract][Full Text] [Related]
11. Optimizing iron chelation strategies in beta-thalassaemia major.
Porter JB
Blood Rev; 2009 Dec; 23 Suppl 1():S3-7. PubMed ID: 20116637
[TBL] [Abstract][Full Text] [Related]
12. Iron chelation therapy for patients with myelodysplastic syndrome.
Yeh SP; Yang YS; Yao CY; Peng CT
Hemoglobin; 2009; 33(5):339-45. PubMed ID: 19814680
[TBL] [Abstract][Full Text] [Related]
13. Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias.
Ault P; Jones K
Clin J Oncol Nurs; 2009 Oct; 13(5):511-7. PubMed ID: 19793708
[TBL] [Abstract][Full Text] [Related]
14. Impact of iron overload in myelodysplastic syndromes.
Fenaux P; Rose C
Blood Rev; 2009 Dec; 23 Suppl 1():S15-9. PubMed ID: 20116635
[TBL] [Abstract][Full Text] [Related]
15. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
[TBL] [Abstract][Full Text] [Related]
16. Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia and iron overload.
Buchbinder D; Nugent D; Vu D; Soni A; Stites J; Hsieh L; Puthenveetil G
Pediatr Transplant; 2012 May; 16(3):E69-73. PubMed ID: 21108711
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
Majhail NS; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863
[TBL] [Abstract][Full Text] [Related]
18. Treatment of iron overload in thalassemia.
Cianciulli P
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():208-13. PubMed ID: 19337180
[TBL] [Abstract][Full Text] [Related]
19. Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation.
Meo A; Ruggeri A; La Rosa MA; Zanghì L; Morabito N; Duca L
Hemoglobin; 2006; 30(1):131-7. PubMed ID: 16540426
[TBL] [Abstract][Full Text] [Related]
20. Iron overload and toxicity: the hidden risk of multiple blood transfusions.
Shander A; Cappellini MD; Goodnough LT
Vox Sang; 2009 Oct; 97(3):185-97. PubMed ID: 19663936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
